Psychiatry & Neurology Doctors in Springfield, VA Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

Dr. Azra A Farooqui, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 7745 Jewelweed Ct, Springfield, VA 22152 Phone: 703-569-3593

Dr. Cynthia M. Shappell, Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 8348 Traford Ln Ste 400, Springfield, VA 22152 Phone: 703-866-2110

Rais A Khan, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 8348 Traford Ln, Suite 400, Springfield, VA 22152 Phone: 703-866-2100    Fax: 703-451-7539

Dr. Benjamin A Adewale, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 7011 Calamo St, #105, Springfield, VA 22150 Phone: 703-569-8028    Fax: 703-569-8085

Zafar Abdur Rasheed, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 8348 Traford Ln, 4th Floor, Springfield, VA 22152 Phone: 703-866-2100

News Archive

Study finds widespread support for public health measures to limit spread of COVID-19

No mass gatherings. Stay-at-home orders. Nonessential business closures. Use of cloth face coverings. In April, these and other measures were adopted by states to try to mitigate the spread of COVID-19 in the U.S. and across the globe.

Antisense Pharma receives FDA IND authorisation for clinical studies with trabedersen for high-grade glioma

The biopharmaceutical company Antisense Pharma announced today that the US-American Food and Drug Administration (FDA) has issued an Investigational New Drug (IND)-authorisation for clinical studies with trabedersen for patients with high-grade glioma. This authorisation entitles the company to include US-American clinics both in the phase III study SAPPHIRE and in further studies.

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

Small businesses prepare for health reform changes

As business owners across the country consider the newly enacted health overhaul, "they're looking to Massachusetts for harbingers of things to come. Massachusetts' law, which mandates near-universal coverage and requires that businesses with 11 or more workers offer insurance, provided the blueprint for the health law signed by President Barack Obama.

Read more Medical News

› Verified 6 days ago